Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 15Gastrointestinal 15Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 94Leukemia, Myeloid, Chronic-Phase 25Leukemia 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Blast Crisis 9Philadelphia Chromosome 4Myeloproliferative Disorders 4Leukemia, Myeloid 4Bone Marrow Diseases 4Recurrence 3Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Hematologic Diseases 3Bronchiolitis Obliterans Syndrome 3Neoplasm, Residual 2Hematologic Neoplasms 2Substance Withdrawal Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Piebaldism 1Neoplastic Processes 1Neoplasms by Histologic Type 1Neoplasms 1Mastocytosis, Systemic 1Hypereosinophilic Syndrome 1Gastrointestinal Stromal Tumors 1

Interventions

Imatinib Mesylate 4trametinib 1ripretinib 1nilotinib 1dabrafenib 1Thalidomide 1High-Energy Shock Waves 1Fentanyl 1Docetaxel 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × nilotinib × Other hematologic neoplasm × Clear all
NCT01735955 2024-02-08

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Novartis

Phase 4 Completed
57 enrolled 8 charts
GastrointestinalLymphoidMyeloidOther hematologic neoplasmSarcoma

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Piebaldism, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡